阿维菌素高产菌株的选育Ⅰ

目的：全面了解阿维菌产生菌S.avermitilis的生长特性并获得阿维菌素的高产菌株。方法：以S.avermitilis Y20为出发菌株,考察该菌株的菌落特征和发酵特性,分别利用紫外线（UV）、亚硝酸（HNO3）及亚硝基胍（NTG）并结合L－异亮氨酸（L－Ⅱe）诱导等手段对出发菌株Y20进行诱变处理。结果：获得高产阿维菌素变异株H336,发酵单位达到852μg/ml。结论：与出发菌株相比,突变株阿维菌素的产量稳定,发酵单位提高了10倍以上。     

阿维菌素生产菌的常压室温等离子体诱变育种及培养基优化

【目的】通过诱变筛选技术选育阿维菌素高产突变株,对其发酵培养基进行响应面优化,提高阿维菌素产量。【方法】采用常压室温等离子体(ARTP)诱变技术,结合链霉抗性和卡那霉素抗性筛选法及96深孔板高通量筛选法,筛选阿维菌素高产株。在单因素实验的基础上,应用响应面分析法对其发酵培养基进行优化,最后确定最佳培养基配方。【结果】获得一株遗传性状稳定的阿维菌素高产株K-1A6,其阿维菌素产量达到4.22 g/L,比出发菌株9-39提高了23.4%,在最佳培养基中阿维菌素产量达到5.36 g/L,较优化前提高了27.01%。【结论】通过对阿维链霉菌9-39菌株进行ARTP诱变筛选及发酵培养基优化研究能显著提高阿维菌素的产量。     

氮源对L-苏氨酸发酵的影响

以L-苏氨酸生产菌TRFC为供试菌株,研究了氮源对L-苏氨酸发酵的产量和糖酸转化率的影响。首先通过摇瓶实验确定发酵的最佳无机氮源和有机氮源分别为硫酸铵和酵母粉,进一步利用10L罐补料分批发酵确定硫酸铵和酵母粉的最佳用量,继续优化培养条件,采用发酵中后期流加硫酸铵和糖氨混合补料等措施,L-苏氨酸产量得到进一步的提高。在最优发酵条件下,通过10L罐补料分批发酵36h,产酸可达118.9g/L,糖酸转化率为47.6%。     

氮源对灵芝菌丝体液态深层发酵合成灵芝三萜的影响

以沪农灵芝1号为供试菌株,葡萄糖作为碳源,用硫酸铵、氯化铵、鱼粉蛋白胨、胰蛋白胨和酵母粉作为氮源,研究不同种类氮源对灵芝菌丝体液态深层发酵过程的影响。首先,确定了N-10酵母自溶粉作为发酵的氮源,降低了发酵的复杂性和不确定性;其次,考察N-10酵母自溶粉不同浓度对灵芝菌丝体发酵合成灵芝三萜过程中菌丝体的生物量、葡萄糖消耗、灵芝三萜产量等方面的影响,确定了N-10酵母自溶粉的适宜添加浓度。在此基础上,采用响应面中心组合设计,对4因素最佳水平范围进行研究,结果表明,葡萄糖、N-10酵母自溶粉、磷酸二氢钾和七水硫酸镁的含量分别为31.06g/L、2.76g/L、1.77g/L和1.99g/L时,灵芝三萜的理论产量为21.166g/kg干菌丝体,实际发酵产量提高到21.153g/kg干菌丝体。与原工艺相比,新工艺的灵芝三萜产量提高了6.22%。     

基于比较代谢组学的理性优化方法提高阿维菌素产量

【目的】利用比较代谢组学的分析方法,研究不同发酵培养基中阿维链霉菌的胞内代谢差异,揭示合成阿维菌素的关键代谢物和代谢途径,再通过理性优化添加主要关键代谢物,提高阿维菌素产量。【方法】对M1和M2培养基中生长的菌体进行基于GC-MS的胞内代谢组学分析,通过理性添加强化前体代谢物,确定阿维菌素高产培养基。【结果】GC-MS共检测到232种物质,能够精确匹配70种胞内代谢物,通过PCA和PLS分析,最终确定了21种已知的胞内代谢物与阿维菌素的生物合成密切相关。其中乳酸、丙酮酸、琥珀酸、苏氨酸、异亮氨酸、缬氨酸和油脂类物质对阿维菌素的产量影响较为显著。通过单独或组合优化添加这些前体,阿维菌素的产量从5.36 g/L提高到了5.92 g/L,增加了10.4%。【结论】基于比较代谢组学分析的理性优化培养基的方法可有效提高阿维菌素的产量,并为提高当下生物基产品的产量提供了新思路。     

植物碳氮源浸提液对中国皱木耳“黔皱耳1号”液体培养及漆酶活性的影响

为获得适宜的野生中国皱木耳液体发酵培养基,在常规液体PDA培养基中添加一定量的植物碳氮源浸提液,通过对不同碳氮源及其添加量和正交试验筛选,结果表明培养基中同时添加植物碳源小麦5g/L和氮源麦麸10g/L的配方组合培养6d时,其菌丝球生物量干重最高[(1.158 0±0.156 6) g/100 mL],菌丝球密度高,大小均一;比CK[(0.594 8±0.054 7) g/100 mL]提高了94.69%。各配方漆酶活性9 d内的酶活大小及变化与CK相比有显著不同,植物碳氮源添加物对漆酶的产生有一定的诱导效果,不同诱导培养基下发酵产漆酶活性除玉米粉和CK基质出现先升后降的趋势外,其余均随培养时间的增加,总体呈低幅度的下降趋势。本研究将为中国皱木耳的人工栽培液体菌种生产提供一定的理论基础。     

阿维菌素高产菌株的选育及阿维菌素B1的鉴定

自阿维链霉菌(Streptomyces avermitilis ATCC31272)中分离出了3种不同类型的菌株,其中只有产灰色孢子的菌株能产生阿维菌素(Avermectins),摇瓶发酵单位约100μg/mL。经高频电子流诱变和对发酵培养基的改进,选育出Sa-76菌株,其摇瓶发酵单位可达1000μg/mL。从其菌丝体中提取纯化了阿维菌素B₁晶体,其紫外吸收光谱、红外吸收光谱、核磁共振谱(¹HNMR和¹³CNMR)和质谱与国外报道的一致。Sa-76菌株又经2次亚硝基胍诱变,筛选出发酵单位2000μg/mL以上的Sa-76-8菌株。在此基础上,再次用亚硝基胍对Sa-76-8菌株进行了诱变,获得Sa-76-9菌株,结合发酵条件的优化,其发酵单位可高达3500～4000μg/mL。     

阿维菌素的研究进展

阿维菌素作为一种占主导地位的生物农药具备一般生物农药的特点,并且它的化学结构新颖,作用机制独特,杀虫活性强,杀虫谱广,但是药效慢、杀虫谱相对较窄、稳定性差和生产成本高则是其明显的缺点。该文主要从阿维菌素B1提取的研究、发酵培养基的研究、高产菌株的选育的研究这三个方面对阿维菌素目前研究的成果及其存在的问题进行了详细的阐述,并对其未来一段时间内的研究前景进行了展望。参考文献18篇。     

基于活细胞量测量的利福霉素发酵过程氮源优化策略

在发酵生产利福霉素SV的过程中,其菌丝体的生长代谢情况及产物发酵合成都与有活力的菌丝量密切相关.介绍了在线活细胞传感仪测定活细胞量的方法,它利用细胞的介电特性,能够排除发酵液中固含物的干扰,测得的电容值与活细胞浓度呈线性相关,可以作为工艺优化过程中的关键参数.通过电容变化反映的前期生长出现的二次生长现象,进行了通过使用迟效氮源豆饼粉代替了原培养基中价格昂贵的速效氮源蛋白胨,成功消除了发酵前期由于氮源利用转换造成的生长停滞期,利用豆饼粉情况下培养前期的OUR和CER达到了14.8和15.3 mmol/L/h,明显高于利用速效氮源蛋白胨A组的8.6和11.3 mmol/L/h,保证了持续较高的比生长速率,对于促进菌体的氧消耗速率的增加和维持有着重要的作用,明显有利于利福霉素的合成与速率的维持,氮源替代组的发酵效价达到了5969±19 U/ml,与对照组(5030±17U/ml)相比显著提升发酵单位18.7%以上.     

赤霉素发酵溶氧优化调控研究

为了解溶氧对赤霉素发酵过程影响以及相应工艺优化,采用不同溶氧条件下藤仓赤霉菌Gibberella fujikuroi分批发酵生产赤霉素的过程进行菌丝浓度、残糖浓度和GA3产物浓度检测,并微分运算得出比生长速率与比产物合成速率随发酵时间变化,分析了溶氧对比生长速率与比产物合成速率以及得率的影响,进而提出Gibberella fujikuroi发酵高产的溶氧控制策略:在发酵初始阶段(0–50h)控制溶氧30%左右,以维持较高的菌体生长速率;发酵中后期(50–184h),溶氧控制在15%,以获取菌丝持续较高的GA3合成速率能力。采用这一优化溶氧控制策略,发酵过程中最大菌丝浓度19.24g/L、最终赤霉素浓度2 180mg/L和平均比产物合成速率0.616mg/(g·h),比未优化前发酵分别提高了8.33%、13.25%和4.58%,表明所采取的分阶段溶氧控制策略对促进GA3生产有效。     

阿维链霉菌bkdAB的基因中断对阿维菌素合成的影响

以阿维菌B组分菌株StreptomycesavermitilisBjbm0 0 0 6为出发菌株 ,用PCR的方法构建bkdAB基因簇(Branched_chainα_ketoaciddehydrogenasegeneAB)的基因置换质粒pHJ582 1(pHZ13 58∷bkdAB&erm) ,并对其进行基因中断 ,得到重组菌株Bjbm582 1。Bjbm582 1的发酵产物经HPLC检测发现 ,除了产生B1a和B2a外 ,还产生一种原菌株没有的新组分 ,3个组分的总含量只有出发菌株Bjbm0 0 0 6的 2 5%。结果表明bkdAB的中断不仅部分阻断了阿维菌素的合成 ,还阻断了阿维菌素b组分的合成 ,可以推测bkdAB的产物在阿维菌素合成途径中主要承担了α酮基异戊酸脱氢酶 (α_ketoisovalericaciddehydrogenase)角色     

Overexpression of the ABC transporter AvtAB increases avermectin production in Streptomyces avermitilis

Avermectins are 16-membered macrocyclic polyketides with potent antiparasitic activities, produced by Streptomyces avermitilis. Upstream of the avermectin biosynthetic gene cluster, there is the avtAB operon encoding the ABC transporter AvtAB, which is highly homologous to the mammalian multidrug efflux pump P-glycoprotein (Pgp). Inactivation of avtAB had no effect, but increasing the concentration of avtAB mRNA 30-500-fold, using a multi-copy plasmid in S. avermitilis, enhanced avermectin production about two-fold both in the wild-type and in a high-yield producer strain on agar plates. In liquid industrial fermentation medium, the overall productivity of avermectin B1a in the engineered high-yield producer was improved for about 50%, from 3.3 to 4.8?g/l. In liquid YMG medium, moreover, the ratio of intracellular to extracellular accumulation of avermectin B1a was dropped from 6:1 to 4.5:1 in response to multiple copies of avtAB. Additionally, the overexpression of avtAB did not cause any increased expression of the avermectin biosynthetic genes through RT-PCR analysis. We propose that the AvtAB transporter exports avermectin, and thus reduces the feedback inhibition on avermectin production inside the cell. This strategy may be useful for enhancing the production of other antibiotics.     

Targeted gene disruption of the avermectin B O-methyltransferase gene in Streptomyces avermitilis

The biological activity of avermectin B components is superior to that of avermectin A components, which are derived from avermectin B by avermectin B 5-O-methyltransferase. Gene disruption, targeting avermectin B 5-O-methyltransferase gene in Streptomyces avermitilis, was carried out to obtain a strain of avermectin B producer. Phenotype analysis of the mutant with the disrupted O-methyltransferase gene showed that only avermectin B components were produced with a significant increase in production     

Stimulation of avermectin B1a biosynthesis in Streptomyces avermilitis by feeding glucose and propionate

The biosynthetic ability of avermectin B1a in Streptomyces avermilitis was improved with propionate addition and glucose feeding. The results showed that B1a production was increased by 12.8–13.8% through supplement of 0.8% propionate at 24 h of cultivation. A stronger stimulation on B1a biosynthesis in S. avermilitis was observed by 3.0% glucose feeding at 5 d of cultivation. The B1a biosynthesis could be further enhanced by repeated glucose fed-batch process in a 10-l bench-top fermentor. A maximal B1a concentration of 780.0 mg/l was obtained by repeated 1.0% glucose addition on 4 d, 5 d and 6 d, which was 2.1-fold higher than that in a control fermentation. Corresponding with this, an additional 6.8% increase of B1a proportion was observed in comparison with the control process. This stimulation on avermectin B1a production was obvious even in a 2000-l fermentor under suitable control of aeration.     

Studies on the biosynthesis of avermectins

To elucidate the pathway of avermectin biosynthesis, the biosynthetic relationships of avermectins A1a, A2a, B1a, B2a, and their respective monosaccharides and aglycones were studied. 14C-labeled avermectin compounds prepared from [1-14C]acetate were fed to Streptomyces avermitilis strain MA5502 and their metabolites were determined. Two furan ring-free aglycones, 6,8a-seco-6,8a-deoxy-5-keto avermectin B1a and B2a, have been isolated from the fermentation broth of a blocked mutant of S. avermitilis. Addition of the compounds and a semisynthetic compound, 5-keto avermectin B2a aglycone, to the fermentation medium of a second blocked mutant established that the two compounds are intermediates in the avermectin biosynthetic pathway immediately preceding avermectin aglycones.     

Synthesis of new, potent avermectin-like insecticidal agents

4'-Modified avermectin derivatives were designed and synthesized. Some of the new synthetic compounds showed excellent in vivo bioactivity against cabbage larvae when compared to commercially available avermectin B1a. In this synthesis, uncommon thioglycosyl sugar donors, prepared from the hydrolysis of natural antibiotics, proved compatible with sugar-macrolide synthesis in the presence of N-iodosuccinimide (NIS) or I2 in N-methylpyrrolidone at room temperature.